This fact sheet provides information on how to treat patients with Probable Mild Axonal Peripheral
Neuropathy with different symptoms, situations and circumstances.
Please note this fact sheet is only designed as a brief summary of management.
We asked you in January to update to v4.7.2. After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.
To update to the latest release:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Welcome to the February 2025 update from the RDS team
A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:
The release will also incorporate a number of small fixes, including:
We will let you know when the date and time for the new release are confirmed.
There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.
The Benzodiazepine tapering tool is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.
Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.
At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .
We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.
Some important toolkits in development by the RDS team include:
The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.
To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)
To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form - also available in End-user and Provider sections of the RDS Learning and Support area. If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.
With kind regards
Right Decision Service team
Healthcare Improvement Scotland
This fact sheet provides information on how to treat patients with Probable Mild Axonal Peripheral
Neuropathy with different symptoms, situations and circumstances.
Please note this fact sheet is only designed as a brief summary of management.
Peripheral neuropathy has a long list of causes, some of which are treatable, such as diabetes, toxic or autoimmune disorders. Other causes, such as genetic, are useful to identify even if there is no current treatment. In practice, a large proportion of peripheral neuropathic symptoms are either not due to an identifiable peripheral neuropathy, or a consequence of axonal degeneration, especially in older people. These patients usually follow a benign course, do not become disabled and often do not need to see a neurologist. This fact sheet is aimed at providing information for this group to support their management in primary care. It is not a substitute for detailed information about peripheral neuropathy, or causes of lower limb numbness.
Sometimes, but there are many other causes. Lumbosacral radiculopathy commonly causes paraesthesia in the feet, as does compression of the peroneal nerve at the fibular head. People with restless legs syndrome commonly complain of burning feet and individuals who hyperventilate may experience intermittent paraesthesia in their feet. Neuropathies tend to cause persistent (if variable) symptoms, not intermittent. If people can identify times when their extremities are normal, a neuropathy is unlikely as intermittent sensory symptoms are common in the normal population.
Over the age of 60, around a third of people lose vibration sense at the big toe and around 20% of people lose their ankle reflexes. Approximately 13% of the UK population over the age of 80 probably have some degree of polyneuropathy – which is nearly all axonal. We cannot, and do not, need to see all of these individuals so it is a case of doing what is reasonable and providing sensible advice.
Patients with the following features can usually be managed conservatively in primary care:
This is just a guide and it is difficult to make fixed rules. Please seek our advice if unsure.
In an older person with mild sensory distal symptoms as above who you have already investigated, we suggest:
Generally, the answer is no. These drugs are for neuropathic pain, not sensory symptoms and they have side effects. They may be useful in moderate to severe symptoms where pain is the issue, but they rarely help non-painful sensory symptoms.
Based on:
Overell JR. Peripheral neuropathy: pattern recognition for the pragmatist. Pract Neurol. 2011 Apr;11(2):62-70. DOI: 10.1136/jnnp.2011.241612